ExpreS2ion Biotech Stock Forecast - Double Exponential Smoothing
EXPRS2 Stock | SEK 18.74 0.38 1.99% |
The Double Exponential Smoothing forecasted value of ExpreS2ion Biotech Holding on the next trading day is expected to be 17.98 with a mean absolute deviation of 1.45 and the sum of the absolute errors of 85.26. ExpreS2ion Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast ExpreS2ion Biotech stock prices and determine the direction of ExpreS2ion Biotech Holding's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of ExpreS2ion Biotech's historical fundamentals, such as revenue growth or operating cash flow patterns.
ExpreS2ion |
ExpreS2ion Biotech Double Exponential Smoothing Price Forecast For the 28th of November
Given 90 days horizon, the Double Exponential Smoothing forecasted value of ExpreS2ion Biotech Holding on the next trading day is expected to be 17.98 with a mean absolute deviation of 1.45, mean absolute percentage error of 8.05, and the sum of the absolute errors of 85.26.Please note that although there have been many attempts to predict ExpreS2ion Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that ExpreS2ion Biotech's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
ExpreS2ion Biotech Stock Forecast Pattern
Backtest ExpreS2ion Biotech | ExpreS2ion Biotech Price Prediction | Buy or Sell Advice |
ExpreS2ion Biotech Forecasted Value
In the context of forecasting ExpreS2ion Biotech's Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. ExpreS2ion Biotech's downside and upside margins for the forecasting period are 10.75 and 25.22, respectively. We have considered ExpreS2ion Biotech's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Double Exponential Smoothing forecasting method's relative quality and the estimations of the prediction error of ExpreS2ion Biotech stock data series using in forecasting. Note that when a statistical model is used to represent ExpreS2ion Biotech stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.AIC | Akaike Information Criteria | Huge |
Bias | Arithmetic mean of the errors | -0.4275 |
MAD | Mean absolute deviation | 1.4451 |
MAPE | Mean absolute percentage error | 0.0391 |
SAE | Sum of the absolute errors | 85.2595 |
Predictive Modules for ExpreS2ion Biotech
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as ExpreS2ion Biotech. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of ExpreS2ion Biotech's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Other Forecasting Options for ExpreS2ion Biotech
For every potential investor in ExpreS2ion, whether a beginner or expert, ExpreS2ion Biotech's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. ExpreS2ion Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in ExpreS2ion. Basic forecasting techniques help filter out the noise by identifying ExpreS2ion Biotech's price trends.ExpreS2ion Biotech Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with ExpreS2ion Biotech stock to make a market-neutral strategy. Peer analysis of ExpreS2ion Biotech could also be used in its relative valuation, which is a method of valuing ExpreS2ion Biotech by comparing valuation metrics with similar companies.
Risk & Return | Correlation |
ExpreS2ion Biotech Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of ExpreS2ion Biotech's price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of ExpreS2ion Biotech's current price.Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
ExpreS2ion Biotech Market Strength Events
Market strength indicators help investors to evaluate how ExpreS2ion Biotech stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading ExpreS2ion Biotech shares will generate the highest return on investment. By undertsting and applying ExpreS2ion Biotech stock market strength indicators, traders can identify ExpreS2ion Biotech Holding entry and exit signals to maximize returns.
ExpreS2ion Biotech Risk Indicators
The analysis of ExpreS2ion Biotech's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in ExpreS2ion Biotech's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting expres2ion stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Mean Deviation | 4.06 | |||
Standard Deviation | 7.19 | |||
Variance | 51.63 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Thematic Opportunities
Explore Investment Opportunities
Other Information on Investing in ExpreS2ion Stock
ExpreS2ion Biotech financial ratios help investors to determine whether ExpreS2ion Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in ExpreS2ion with respect to the benefits of owning ExpreS2ion Biotech security.